CAV1 and neoplasm: CAV1 expression in cancer cells reduces HIF1α transcriptional activity in hypoxia by reducing HIF1α S-nitrosylation and, as a consequence, the transcription of VEGF, which likely limits tumor growth and contributes to the tumor suppressor function of CAV1 in the absence of E-cadherin.